At Home With Art
Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art
Krishna Gopalan - August 19, 2017
Managing Growth 2017- Part 2
Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal
March 17, 2017
Making A Fresh Start
CEOs from diverse sectors on what's in store for 2017
March 17, 2017
Will Sun rise again?
Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?
Kripa Mahalingam - June 15, 2015
Critical condition
Drug majors are shifting clinical trials out of India as lawmakers turn on the heat
Kripa Mahalingam - June 17, 2015